Always cite the published version, so the author(s) will receive recognition through services that track citation counts, e.g. Scopus. If you need to cite the page number of the TSpace version (original manuscript or accepted manuscript) because you cannot access the published version, then cite the TSpace version in addition to the published version using the permanent URI (handle) found on the record page. 
INTRODUCTION
HIV disproportionately affects transgender women in the global pandemic, including in Caribbean countries. 1, 2 Latin American-based studies, some of which include the Caribbean, report that over one-quarter of transgender women are living with HIV. 3 A systematic review and meta-analysis including transgender women (n=7179) purposively sampled from ten lowand middle-income countries (LMIC) reported an HIV prevalence of 17.7% (95% CI: 15.6-19.8). 4 Transgender women experience HIV rates almost 49 times higher than national prevalence estimates across high and LMIC. 4 Yet in Caribbean contexts, 5 including in Jamaica, there is limited knowledge about HIV prevention and care needs among transgender women.
Jamaica is one of several Caribbean countries that has established a comprehensive response to the HIV epidemic, 6 resulting in a substantially reduced HIV incidence and a current HIV prevalence of 1.7% (95% CI: 1.4-2.0) among the adult general population. 7 Yet the criminalization of "homosexuality" in Jamaica may contribute to elevated HIV infection rates among sexual and gender minorities (SGM). For example, the estimated HIV prevalence among men who have sex with men (MSM) in Jamaica is between 28% to 32%, among the highest in the Caribbean. 8, 9 Scant research has examined HIV prevalence among transgender women in Jamaica, who face similar experiences of stigma and discrimination as MSM. Figuero et al.'s 9 study with MSM (n=449) in Jamaica included 17 transgender women with reported HIV infection rates of 52.9%. We located no studies focused on assessing HIV prevalence, correlates of HIV testing, or correlates of HIV infection among transgender women in Jamaica.
Social and structural drivers that elevate transgender women's HIV exposure include the criminalization of homosexuality, violence, stigma and discrimination. Criminalization of SGM limits access to the HIV prevention and care continuum, 10 from HIV testing and diagnosis to viral suppression. [10] [11] [12] Community-based organizations report pervasive violence towards SGM populations from both within their families and in the broader community. 13, 14 Globally transgender women experience higher rates of violence and incarceration than non-transgender women. 15 SGM in Caribbean countries experience stigma and discrimination, family rejection, and a lack of human rights protections in employment, education systems, and the State. 16 These factors contribute to economic insecurity, including poverty and homelessness, that elevate HIV vulnerability 16, 17 and decrease access to HIV testing. 18 Economic insecurity plays a role in the high rates of sex work among transgender populations, particularly in Caribbean and Latin
American countries, with upwards of 60% of samples reporting sex work involvement. 19, 15 HIVrelated stigma also presents a formidable barrier to HIV testing uptake in Jamaica. In a study of incarcerated men in Jamaica (n=298), HIV-related stigma was associated with decreased likelihood of ever receiving an HIV test. 20 In a qualitative study with health and social service providers, PLHIV and SGM reported that both HIV-related and sexual stigma reduced uptake of, and access to, HIV testing, treatment and care services. 21 The lack of confidentiality about sexuality and HIV in health care facilities leads to distrust that reduces health services utilization. 22 Understanding factors associated with HIV infection and HIV testing among transgender women in the Jamaican is critical to enhance access to the HIV care cascade. HIV testing is the first step in the HIV care cascade, facilitating diagnosis and linkage to care, initiation of antiretroviral treatment, and viral suppression -which may optimize the health of transgender women as well as prevent HIV transmission.
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Study objectives
The study objective was to enhance knowledge of correlates of HIV infection and HIV testing uptake among transgender women in Jamaica. We aimed to: 1) determine HIV prevalence and the proportion of participants ever tested for HIV; and, 2) determine correlates of HIV infection and ever having received an HIV test.
METHODS
Sampling and data collection
In collaboration with a national AIDS Service Organization (X: blinded for peer review)
we conducted a cross-sectional survey with transgender women in Kingston and Ocho Rios, Jamaica, as well as from surrounding areas of these cities between March 2015-October 2015.
Participants were eligible to complete the survey if they identified as a transgender women over 18 years old currently residing in Jamaica.
We utilized purposive, non-random sampling methods to access this highly marginalized population. There were no print materials (e.g. flyers, posters) due to the lack of legal protection among transgender women in Jamaica. We recruited and trained 7 peer research assistants (PRAs) across study sites who self-identified as a sexual or gender minorities (lesbian, gay, bisexual, transgender towards transgender persons. The scale was adapted to replace each item "because of your homosexuality" to "because you are transgender". Enacted stigma refers to discriminatory acts, including violence, harassment and mistreatment. 31 The perceived transgender stigma scale 
Data analysis
We conducted descriptive analyses for socio-demographic variables (e. Table 1 reports participant socio-demographic characteristics, HIV testing and prevalence outcomes, and intra/interpersonal and structural factors (n=137). The mean age was 24.0 years 
RESULTS
Participant characteristics
Univariate and multivariate modeling of HIV testing among transgender women
In univariate analyses ( on the HIV-related stigma scale, the predicted probability of HIV testing was 97.2%, whereas if a participant scored 100 on the HIV-related stigma scale, the predicted probability of HIV testing was 58.4%.
Univariate and multivariate modeling of HIV status among transgender women
In univariate analyses, perceived poverty, perceived HIV risk, depression, need for social support, forced sex history, physical abuse history, perceived transgender stigma, enacted transgender stigma, lower self-rated health, and homelessness were associated with increased odds of being HIV-positive. Being employed and having higher quality of social support were associated with decreased odds of being HIV-positive.
In multivariable analyses ( Perceived and enacted transgender stigma were higher among HIV-positive participants.
With a one unit increase in the perceived transgender stigma score, the likelihood of being HIV positive increased by 26.5%. As shown as Figure 2 , the predicted probability of being HIVpositive if a participant scored 5 on the perceived transgender stigma scale was 2.2%, whereas the probability was 27.9% if the participant scored 20. With a one unit increase in the score on the enacted transgender stigma scale, the likelihood of being HIV positive increased by 15.7%. Figure 3 depicts that the predicted probability of being HIV positive if a participant scored 7 on the enacted transgender stigma scale was 6.2%, whereas the probability was 54.8% with a score of 30.
DISCUSSION
The high HIV prevalence in this study highlights transgender women in Jamaica as a key population to involve in the HIV prevention and care continuum. Lifetime history of other STIs was highly associated with being HIV-positive, underscoring the need to include STI testing and prevention as part of the HIV prevention and care continuum in the Jamaican context. Onequarter of participants were never tested for HIV; with a 25% rate of seropositivity, this rate of testing is concerning as it is likely that a proportion of our sample are living with HIV undiagnosed, limiting their access to early treatment, care, and support. Importantly, our findings suggest that participants who engaged in practices that elevate the risk of HIV exposure (drug use, getting drunk or high when having sex) were less likely to have received an HIV test.
Tailored educational interventions to increase perceived HIV risk among highly marginalized populations (e.g., transgender women who use drugs) may promote HIV testing uptake.
Strategies are required to increase accountability, sensitivity and privacy in HIV testing and care services.
Our study highlights complex, multi-level factors associated with HIV testing and HIV infection that reflect the social ecological model. Social ecological perspectives situate HIV risk in larger social and structural contexts, including intrapersonal (e.g., mental health), interpersonal/social (e.g., social support), and structural (e.g., healthcare access, stigma)
factors. 35 HIV-related stigma was a barrier to HIV testing, corroborating qualitative work in Jamaica 21 and quantitative work in other contexts. 33, [36] [37] [38] Transgender stigma was higher among participants who had ever received an HIV test in comparison with those never tested, and higher among HIV-positive participants in comparison with HIV-negative participants. It is plausible that transgender women encounter transgender stigma upon accessing HIV testing and care services. For example, a recent study in Jamaica and the Bahamas with 332 healthcare and social service providers reported stigmatizing attitudes, most strongly in relation to MSM living with HIV. 39 Prior research in Jamaica has highlighted healthcare worker resistance to working with sexual minorities and PLHIV. [39] [40] [41] It is also possible that transgender stigma could be a distal HIV risk factor and elevate HIV infection riskslongitudinal studies are warranted to better understand the associations between HIV positive serostatus and transgender stigma. There is a growing body of literature that suggests that HIV self-testing, administered in a location of an individual's choosing, is acceptable to transgender women and may address concerns with privacy, confidentiality, and stigma (HIV-related, transgender) often encountered by transgender women in the context of clinic-based HIV testing. [42] [43] [44] However, in the absence of structural interventions to address stigma in healthcare settings, transgender women living with HIV may continue to experience barriers accessing the HIV care continuum.
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HIV positive participants were 6-fold more likely to be homeless, and a history of continuum.
There are a few limitations inherent in our study design. The non-random sampling method, while necessary in accessing such a hidden and vulnerable population, limits generalizability of findings to other transgender women in Jamaica. The cross-sectional study design precludes understanding causality and necessitates a cautious interpretation of our findings. Data collected was self-reported, and is therefore subject to recall bias and social desirability bias. While we found having multiple partners/polyamoury was associated with HIV testing uptake, future studies could examine multiple partners/polyamoury as a distinct category rather than a relationship status, as persons of various relationship statuses can have multiple partners. We found an overall HIV prevalence of 25% through combining self-reported HIV status with HIV positive laboratory test results in our study. However, HIV testing was voluntary and only 22% of participants chose to receive an HIV test in this study. The low rate of testing uptake could be related to high rates of baseline seropositivity; it is also possible that participants who had ever received an HIV test did not feel the need to receive another. Our findings could therefore underreport HIV infection rates among this sample of transgender women.
Despite these limitations, this was among the first studies to assess HIV status and testing rates among transgender women in Jamaica, a highly vulnerable population among whom we identified extremely high HIV prevalence. Combination HIV prevention approaches may be crucial for Jamaican transgender women given the many social-structural vulnerabilities identified; these might include: increased access to voluntary HIV testing and counselling;
psychosocial support for depression and substance use; gender-based violence prevention; HIV and transgender stigma reduction campaigns; access to survival needs, in particular employment and housing; and legal protection from discrimination. Future research and interventions could address the syndemics 45, 46 of violence, economic insecurity and mental health challenges that elevate HIV vulnerability among this population. Addressing social ecological contexts of HIV risk is necessary to advance HIV prevention among transgender women in Jamaica. 
